Downstream Processing World Congress 2015

Guest blog: Is automation the key to consistent drug quality?

Dr Nick Hutchinson, Market Development Manager (Pharma & Biotech) at Parker domnick hunter reveals the origins of the SciLog® SciFlex® Filter and Dispense System, which will be showcased at this year’s Downstream Processing World Congress. Automating a bioprocess step reduces variation, increases productivity, prevents manual errors and frees up operator time, as well as improving health & safety and working …

Downstream Processing World Congress 2015

Brochure available for Downstream Processing World

Explore the technology of the future including 3D printed chromatography columns and a portable bioreactor that can produce AND purify a biologic drug. Downstream Processing World Congress will be showcasing the cutting edge in what is possible for downstream this February. Use our roundtables sessions on chromatography, continuous and single-use technologies hosted by top solution providers and interactive on-floor demonstrations …

Top 25 Representatives in Bioprocessing

Top 25 Representatives in Bioprocessing

This is the question we asked our subscribers, LinkedIn group members and anyone in our contact network to compile a comprehensive list of the Top 25 Representatives in Bioprocessing, as named by you. Download this ebook now. The following 25 personalities have been chosen based on their career achievements, whether this was ground-breaking discovery and research, or innovation, funding, lifetime dedication …

Increase in Continuous Processing and Single-Use in Future Biomanufacture Forecast in New Review

A review by Institute for Separation and Process Technology has predicted an increase in the use of single use technologies and continuous processing within the manufacture of biologics in the future. Researchers Jochen Strube, Reinhard Ditz and Petra Gronemeyer, predict that demands for high quality biologics will continue to increase in the coming decades. Decreasing production and imminent patent expirations of ‘blockbuster’ drugs coupled with a …

Genzyme to Implement Upstream and Downstream Continuous Bioprocess

A patent has just been filed by Genzyme for a new technology platform that will integrate upstream and downstream bioprocess, creating a fully continuous process for biologics manufacture. Genzyme’s new patent claims to combine an upstream perfusion system with a dual stage chromatography process to extract biologics. The first purification stage being a multi-column chromatography system the second consisting of …

Continuous integrated upstream and downstream processes: a viable option for the future of big pharma?

Is a continuous upstream and downstream process a viable option for the future? Integrated upstream and downstream technology seems to be the ‘holy grail’ of what can be expected for the future of biosimilar drug extraction. Industry pharma leaders such as Genzyme, GE Healthcare, and Novo Nordisk and CMO companies such as Gallus and Rentschler are all working on pushing the …

Top strategies for improving cell culture scale-up

Can a scale-up process de designed which delivers consistency and prevent the need for extensive redevelopment at such a late downstream stage? This is the question posed by Sasa Stojkovic, Head of Pilot Bioprocess Department at Sandoz at the Cell Culture World Congress . Sasa went on to highlight the need for technologies which can monitor parameters throughout bioproduction to …